A new healthcare framework named the "Great Healthcare Plan" has been introduced by Donald Trump, with the aim of reducing prescription drug prices and insurance premiums. This comes amidst issues in extending key Affordable Care Act tax credits in the Senate, potentially leading to higher premiums. The plan, focused on cost relief rather than boosting insurer subsidies, includes measures such as implementing most-favored-nation drug pricing, expanding direct-to-consumer discounted drug sales, and reallocating insurance funding to individuals instead of insurers. Additionally, cost-sharing reductions could result in reducing common Obamacare plan premiums by more than 10%, along with the enforcement of broader price-transparency regulations. The proposal is perceived as politically attractive, though its implementation remains uncertain. In other news, the U.S.-Taiwan chip deal has brought a reset in the trade relations.